XML 24 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
4. Cash, Cash Equivalents, and Marketable Securities
6 Months Ended
Jun. 30, 2018
Cash, Cash Equivalents, and Short-term Investments [Abstract]  
Cash, Cash Equivalents, and Marketable Securities
4. Cash, Cash Equivalents, and Marketable Securities

We consider highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents with the exception of time deposits, which are presented as marketable securities. Cash, cash equivalents, and marketable securities consisted of the following at June 30, 2018 and December 31, 2017 (in thousands):
 
 
June 30,
2018
 
December 31,
2017
Cash and cash equivalents:
 
 
 
 
Cash
 
$
1,804,118

 
$
2,142,949

Money market funds
 
220,373

 
125,585

Total cash and cash equivalents
 
2,024,491

 
2,268,534

Marketable securities:
 
 
 
 
Foreign debt
 
299,961

 
238,858

Foreign government obligations
 
117,771

 
152,850

U.S. debt
 
38,562

 
73,671

Time deposits
 
654,127

 
255,000

Total marketable securities
 
1,110,421

 
720,379

Total cash, cash equivalents, and marketable securities
 
$
3,134,912

 
$
2,988,913



The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within our condensed consolidated balance sheets as of June 30, 2018 and December 31, 2017 to the total of such amounts as presented in the condensed consolidated statement of cash flows (in thousands):
 
 
Balance Sheet Line Item
 
June 30,
2018
 
December 31,
2017
Cash and cash equivalents
 
Cash and cash equivalents
 
$
2,024,491

 
$
2,268,534

Restricted cash  current (1)
 
Prepaid expenses and other current assets
 
6,554

 
11,120

Restricted cash  noncurrent (1)
 
Restricted cash and investments
 
67,380

 
50,822

Total cash, cash equivalents, and restricted cash
 
 
 
$
2,098,425

 
$
2,330,476


——————————
(1)
See Note 5. “Restricted Cash and Investments” to our condensed consolidated financial statements for discussion of our “Restricted cash” arrangements.

During the three and six months ended June 30, 2018, we sold marketable securities for proceeds of $10.8 million and realized gains of less than $0.1 million on such sales. During the three and six months ended June 30, 2017, we sold marketable securities for proceeds of $15.1 million and $118.3 million, respectively, and realized gains of less than $0.1 million on such sales. See Note 8. “Fair Value Measurements” to our condensed consolidated financial statements for information about the fair value of our marketable securities.

The following tables summarize the unrealized gains and losses related to our available-for-sale marketable securities, by major security type, as of June 30, 2018 and December 31, 2017 (in thousands):
 
 
As of June 30, 2018
 
 
Amortized
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair
Value
Foreign debt
 
$
302,899

 
$
1

 
$
2,939

 
$
299,961

Foreign government obligations
 
118,992

 

 
1,221

 
117,771

U.S. debt
 
38,607

 
2

 
47

 
38,562

Time deposits
 
654,127

 

 

 
654,127

Total
 
$
1,114,625

 
$
3

 
$
4,207

 
$
1,110,421

 
 
As of December 31, 2017
 
 
Amortized
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair
Value
Foreign debt
 
$
240,643

 
$
3

 
$
1,788

 
$
238,858

Foreign government obligations
 
153,999

 

 
1,149

 
152,850

U.S. debt
 
73,746

 

 
75

 
73,671

Time deposits
 
255,000

 

 

 
255,000

Total
 
$
723,388

 
$
3

 
$
3,012

 
$
720,379



As of June 30, 2018, we identified nine investments totaling $144.4 million that had been in a loss position for a period of time greater than 12 months with unrealized losses of $1.6 million. As of December 31, 2017, we identified 16 investments totaling $210.3 million that had been in a loss position for a period of time greater than 12 months with unrealized losses of $1.9 million. Such unrealized losses were primarily due to increases in interest rates relative to rates at the time of purchase. Based on the underlying credit quality of the investments, we do not intend to sell these securities prior to the recovery of our cost basis. Therefore, we did not consider these securities to be other-than-temporarily impaired.

The following tables show unrealized losses and fair values for those marketable securities that were in an unrealized loss position as of June 30, 2018 and December 31, 2017, aggregated by major security type and the length of time the marketable securities have been in a continuous loss position (in thousands):
 
 
As of June 30, 2018
 
 
In Loss Position for
Less Than 12 Months
 
In Loss Position for
12 Months or Greater
 
Total
 
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
Foreign debt
 
$
207,034

 
$
2,040

 
$
57,927

 
$
899

 
$
264,961

 
$
2,939

Foreign government obligations
 
31,273

 
494

 
86,498

 
727

 
117,771

 
1,221

U.S. debt
 
23,549

 
47

 

 

 
23,549

 
47

Total
 
$
261,856

 
$
2,581

 
$
144,425

 
$
1,626

 
$
406,281

 
$
4,207

 
 
As of December 31, 2017
 
 
In Loss Position for
Less Than 12 Months
 
In Loss Position for
12 Months or Greater
 
Total
 
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
Foreign debt
 
$
119,869

 
$
735

 
$
88,919

 
$
1,053

 
$
208,788

 
$
1,788

Foreign government obligations
 
31,467

 
289

 
121,383

 
860

 
152,850

 
1,149

U.S. debt
 
73,671

 
75

 

 

 
73,671

 
75

Total
 
$
225,007

 
$
1,099

 
$
210,302

 
$
1,913

 
$
435,309

 
$
3,012


The contractual maturities of our marketable securities as of June 30, 2018 were as follows (in thousands):
 
 
Fair
Value
One year or less
 
$
820,620

One year to two years
 
128,827

Two years to three years
 
160,974

Total
 
$
1,110,421